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USABILITY AND ACCEPTABILITY OF AN ELECTRONIC CLINICAL DECISION
SUPPORT TOOL FOR ANTIBIOTIC SELECTION FOR COMMON PEDIATRIC
INFECTIONS IN OUTPATIENT RURAL HEALTHCARE CLINICS

An Abstract of the Scholarly Project by
Samantha Kay Simpson

The purpose of this project was to determine the potential role, usability and
acceptability of an electronic clinical decision support tool (ECDST) for optimizing
antibiotic prescribing practices for pediatric patients in outpatient rural healthcare clinics.
Providers working with pediatric patients at Community Health Center of Southeast
Kansas were asked to use the ECDST to complete two case studies. Following
completion of the case studies, participants completed two standardized surveys
regarding usability and mental workload of the ECDST. The ECDST used in this project
was found to require a low mental demand, have a high usability value, and was accepted
as a potential tool for clinical practice by the majority of the providers who used it.

iv

TABLE OF CONTENTS
CHAPTER

PAGE

I. INTRODUCTION.................................................................................................1
Clinical Issue ..................................................................................................1
Significance………………………………………………………………….2
Specific Aims/Purpose ………………………………...................................3
Hypothesis …………………………………………………………………..3
Theoretical Framework.......................................................................................3
Definition of Key Terms ....................................................................................5
Logic Model........................................................................................................6
Summary.............................................................................................................7

II. INTEGRATED REVIEW OF THE LITERATURE...........................................8
The Problem........................................................................................................8
Cost..............................................................................................................10
Morbidity/Mortality……………………………………………………….11
Inappropriate Antimicrobial Use.................................................................12
Possible Solutions..............................................................................................13
Provider Based Education............................................................................13
Electronic Clinical Decision Support Tools (ECDST)……………………14
Summary……………………………………………………………………….15

III. METHODS........................................................................................................17
Project Design ...................................................................................................17
Target Population………………………………………. …………………18
Protection of Human Rights……………………………………………….19
ECDST Development……………………………………………………...20
Instruments………………………………………………………………....20
Procedure…………………………………………………………………..21
Treatment of Data and Evaluation Plan……………………………………22
Summary……………………………………………………………………….23

IV. EVALUATION RESULTS................................................................................24
Introduction…………………………………………………………………….24
Description of Population……………………………………………………...24
Statistical Analysis……………………………………………………………..26

v

CHAPTER ...........................................................................................................PAGE
Analysis of Hypotheses……………………………………………………….29
Summary……………………………………………………………………...32

V. DISCUSSION ...................................................................................................33
Relationship of Outcomes to Research……………………………………….33
Observations………………………………………………………………….34
Limitations……………………………………………………………………35
Evaluation of Theoretical Framework………………………………………..35
Evaluation of Logic Model…………………………………………………...36
Implications for Future Projects and Research……………………………….36
Conclusion……………………………………………………………………38
REFERENCES ......................................................................................................39
APPENDICES .......................................................................................................45
Appendix A…………………………………………………………………..47
Appendix B…………………………………………………………………..48
Appendix C…………………………………………………………………..49
Appendix D…………………………………………………………………..50
Appendix E…………………………………………………………………...51
Appendix F…………………………………………………………………...52
Appendix G…………………………………………………………………..53

vi

LIST OF TABLES
TABLE…………………………………………………………………………..PAGE
1. Demographics……………………………………………………………...25
2. Case Study Results………………………………………………………...30
3. NASA-TLX Results………………………………………………………..31

vii

LIST OF FIGURES
FIGURE…………………………………………………………………………….PAGE
1. Pre-Survey: Percentage of Pediatric Patients Seen Weekly………………….26
2. Pre-Survey: Question 1……………………………………………………….27
3. Pre-Survey: Question 4……………………………………………………….27
4. Pre Survey: Question 5……………………………………………………….28
5. Pre-Survey: Question 6……………………………………………………….29
6. Post-Survey: Question 2……………………………………………………....31

viii

Chapter I

Introduction

Antibiotic resistance has become a global threat, with at least 2 million people
becoming infected with antibiotic resistant bacteria in the United States each year, and at
least 23,000 people dying each year as a direct result of these infections (Centers for
Disease Control and Prevention, 2013). Antibiotic resistance is attributed to multiple
factors, such as overuse and misuse of medications, lack of new drug development, and
the public’s perception and use of these medications (Ventola, 2015). Approximately half
of all outpatient antibiotic prescribing may be inappropriate (eg. incorrect selection of the
antibiotic, dosing, duration, and necessity) and at least thirty percent of outpatient
antibiotics prescribed in the United States are completely unnecessary (Sanchez et al.;
2016 Fleming-Dutra et al., 2016). The pediatric population receive a disproportionately
high number of these antibiotics compared to the middle-aged population (Ready et al.,
2004).
Clinical Issue
The improper use and over prescribing of antibiotics are two of the many factors
surrounding antibiotic resistance that are of great importance to the healthcare
community. These two areas are places that healthcare providers can work to make
improvements. When prescribing antibiotics, the benefits need to be weighed against the
1

possible risks associated with increased resistance and adverse health outcomes. Some of
the areas contributing to the inappropriateness include prescribing for an unnecessarily
prolonged duration, selecting an unnecessarily broad-spectrum antibiotic, or prescribing
an antibiotic when it is not indicated such as for viral infections. The pediatric population
is a great place to begin working on decreasing the number of inappropriate antibiotic
prescriptions, especially for common infections.
Significance
In 2015 alone, 269 million prescriptions for antibiotics were dispensed from
outpatient pharmacies in the United States (CDC, 2017a). That’s enough antibiotics for
five out of every six people to receive one prescription for an antibiotic each year. Only
70% of these antibiotics were prescribed appropriately. The Centers for Disease Control
and Prevention has a National Plan to Combat Antibiotic-Resistant Bacteria (CARB).
Their goal is to reduce inappropriate antibiotic prescriptions by 50% by 2020. All
providers should have this goal in mind to decrease inappropriate antibiotic prescribing to
help decrease the rate of antimicrobial resistance.
Healthcare providers have a moral obligation to diagnose and prescribe
appropriately to the best of their knowledge and education. Antibiotic resistance is an
issue that needs to be dealt with now before lifesaving antibiotics become useless in
fighting common bacterial infections. It is the providers’ duty to use the tools that are
available to diagnose and treat appropriately based on evidence-based practice guidelines
to preserve the antibiotics that are available to fight infections in their patients. All
providers should be searching for innovative ways to help them diagnose and prescribe
antimicrobials appropriately.
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Specific Aims/Purpose
The purpose of this project was to determine the potential role of an electronic
clinical decision support tool (ECDST) for optimizing antibiotic prescribing practices in
rural clinical practice. The specific aim was to evaluate the usability and acceptability of
an ECDST for antibiotic prescribing in pediatric patients in outpatient rural health clinics.
The exploratory aim was to assess the impact of ECDST use on antibiotic prescribing
practices among healthcare providers who used the tool.
Hypothesis
The primary hypothesis was that providers would find that the ECDST requires a
low mental demand and has a high usability value. Based on the exploratory aim, it was
hypothesized that providers would more often choose the correct diagnosis and related
treatment when using the ECDST.
Theoretical Framework
The theoretical framework that provided a basis for implementation of this project
is based on Lawrence Kohlberg’s theory of moral development. Kohlberg’s theory,
developed in 1958, carried over many of the assumptions and criteria from Piaget’s stage
of theory of cognitive development (Snarey & Samuelson, 2008). The theory was an
appropriate framework for this project because of its design in developing and improving
upon one’s morals or values. As providers of healthcare, it is one’s duty to maintain and
provide accurate care for patient’s health. The theory of moral development framework
helped this project by supporting and reinforcing the providers’ mission to improve
overall care and promoting accurate knowledge to improve outcomes by incorporating
evidence into practice. Healthcare professionals have a moral responsibility to treat their

3

individual patients effectively with a public health duty to preserve the efficacy of
antibiotics to minimize the development of resistance for their future patients (Parsonage
et al., 2017).
Kohlberg’s theory’s premise is that everyone has certain moral dilemmas that
determine which stage of moral reasoning a person uses (Snarey & Samuelson, 2008).
nurse practitioners, physicians, and physician assistants must make ethical and moral
decisions every day when providing care for patients. Providers must first do no harm,
and inappropriately prescribing antimicrobials could potentially do more harm than good
and continue to contribute to the crisis of antibiotic resistance. Kohlberg’s theory is
appropriate and well positioned for providers to evaluate new knowledge and gain
expertise to support practice change based on evidence and moral values. Once providers
understand the harm that comes from inappropriate prescribing, they may transform their
beliefs and change the way they practice medicine.
This scholarly project supported services that promote the development of highly
competent providers, and the incorporation of evidence-based practice. The ECDST for
this project uses clinical practice guidelines that include “recommendations intended to
optimize patient care, and they are informed by a systematic review of evidence, and an
assessment of the benefits and harms of alternative care options (AAFP, 2017, para. 1).
The project used this theoretical framework to provide the ability to consider all
aspects of patients and their needs and to actively support the welfare of patients through
personal and professional actions to improve antibiotic prescribing. By educating
providers on the importance of antimicrobial resistance and the use of an ECDST for
treating common pediatric infections, providers may change the way they use
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antimicrobials in their future practice to decrease inappropriate antimicrobial use. Using
this tool, the providers can evaluate new knowledge and gain expertise to support practice
change based on evidence and moral values.
Definition of Key Terms
Throughout this paper, the reader will come across specific terms that will need to
be clearly defined to enable understanding. These terms include the following:
Antibiotic: a substance produced by living organisms and especially by bacteria
and fungi that is used to kill or prevent the growth of harmful germs (Merriam-Webster,
2017).
Antimicrobial: a substance that has the capability of destroying or inhibiting the
growth of microorganisms and especially pathogenic microorganisms (Merriam-Webster,
2017).
Antibiotic / Antimicrobial Resistance (AMR): “the ability of microbes to resist
the effects of drugs – that is, the germs are not killed, and their growth is not stopped.”
(CDC, 2017b, para. 1)
Clinical Practice Guidelines (CPG): "statements that include recommendations
intended to optimize patient care that are informed by a systematic review of evidence
and an assessment of the benefits and harms of alternative care options” (IOM, 2011, p.
4).
Primary Care Provider: A Primary Care Provider (PCP) is a healthcare
practitioner who sees common medical problems. These individuals can be a physician,
nurse practitioner, or physician assistant.

5

Upper respiratory tract infection (URI): a nonspecific term used to describe
some acute infections involving upper respiratory tract (the nose, paranasal sinuses,
pharynx, larynx, trachea, and bronchi).
Logic Model
Situation: Providers are prescribing antibiotics inappropriately

The logic model begins with inputs including: literature review, evidence-based
practice guidelines and development of an ECDST. Outputs include activities and
participation from the providers. The short-term goals depicted in the logic model are
that providers would become aware of the issue of antibiotic resistance, they would find
the ECDST usable with a low mental demand and would change attitudes and motivate
providers to use the ECDST to change prescribing antibiotics inappropriately. Other
outcomes included behavior changes and eventually policy and practice changes in the
clinical setting.

6

Summary
Antibiotic resistance has become a major problem is the U.S. and around the
world. Providers must become aware of the consequences of inappropriate prescribing
and of their role in curbing antibiotic resistance. The purpose of this scholarly project
was to determine the potential role of an ECDST for optimizing antibiotic prescribing
practices in rural clinical practice. The aim was to evaluate the usability and
acceptability of an ECDST for antibiotic prescribing in pediatric patients in outpatient
rural health clinics.
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Chapter II

Review of the Literature

A systematic search of the literature was performed using the electronic databases
CINAHL Plus with Full Text and PubMed, with up-to-date information and research also
obtained from the Centers for Disease Control website. In addition, the reference lists
from each of the articles that were identified as relevant to this literature review were
examined to identify additional references to review. The major concepts reviewed
throughout this synthesis are: the problem, cost, morbidity/mortality of antibiotic
resistance and the problem of overprescribing antibiotics. Possible solutions such as
provider education and the use of electronic clinical decision support tools are also
reviewed throughout this literature review.
The Problem
In the United States (U.S.) alone, over two million people acquire antibiotic
resistant infections with a mortality rate of 23,000 individuals per year (CDC, 2013). The
single most crucial factor leading to antibiotic resistance is the inappropriate prescribing
of antibiotics. Antimicrobial Resistance (AMR) continues to be problematic not only in
the U.S., but globally as well. There is a consensus around the world that this is a
growing health concern and one that needs immediate action. The World Health
Organization (WHO) states “AMR is an increasingly serious threat to global public
8

health that requires action across all government sectors and societies” (World Health
Organization, 2018, para. 1). Resistant organisms are worldwide, with the threat of more
resistant organisms ever increasing.
The prevalence of extended spectrum beta-lactamases (ESBL) producing bacteria
increased from 0.28 percent in 1999 to 0.92 in 2011 (Logan, Braykov, Weinstein, &
Laxminarayan, 2014). It was found that slightly more than half of the isolates of ESBLproducing bacteria were found in those 1-5 years old, and 74% of these bacteria were
resistant to multiple classes of antibiotics. The pediatric population play a large role in
hosting antibiotic resistant bacteria. Rising rates of resistant infections are causing longer
hospitalizations for children in the U.S. and cause a higher risk of death for these children
(Meropol, Haupt & Debanne, 2017). The study also states that three out of five children
admitted to hospitals already have an antibiotic-resistant infection, which suggests that
these infections are spreading within communities.
Antibiotic-resistant Acinetobacter baumannii infections is one of the most
common hospital-acquired infections in children across the United States (Logan et al.,
2018). The rate of these infections is on the rise. A recent study by Logan et al., 2018
show that the number of cephalosporin resistant A baumannii increased from 13.2 percent
of infections in 1999 to 23.4 percent in 2012, whereas the number of carbapenem
resistant A. baumannii increased from 0.6 percent in 1999 to 6.1 percent in 2012.
Acinetobacter are a type of bacteria that are known to cause serious infections and are
difficult to treat because of growing antibiotic resistance. Children with compromised
immune systems and chronic conditions are especially susceptible to these types of
infections.

9

Cost
AMR not only has an impact on health, morbidity, and mortality; it also
overburdens the U.S. health care system. Studies have estimated that in the U.S alone,
AMR “adds $20 billion in excess direct healthcare costs, with additional costs to the
society for lost productivity as high as $35 billion a year” (CDC, 2013, para. 4). In 2009,
approximately $10.7 billion was spent on antibiotic therapy in the United States alone,
including $6.5 billion in the outpatient setting, $3.6 billion in inpatient acute care, and
$526.7 million in the long-term care settings (Suda et al., 2013). Infectious Disease
Society states that “Treating resistant infections costs the U.S. health care system an
estimated $21 billion to $34 billion annually” (IDSA, 2018 para. 2).
The economic burden these infections have on society is high and increasing
every day. Antibiotic resistance adds nearly $1,400 to the medical bill when treating
bacterial infections (Thorpe, Joski & Johnston, 2018). Bacterial infections that are
antibiotic resistant has more than doubled over 13 years, rising from 5.2% in 2002 to
11% in 2014. The overall cost of these infections was 165% higher for patients with
resistant bacteria than those with non-resistant infections. These costs are projected to
increase significantly worldwide.
Olusoji et al. (2017) examined the economic and development consequences of
AMR using the World Bank Group economic simulation tools to see how AMR will
impact the economy in the future. The researchers were able to estimate what the global
economic impact of AMR would be from 2017 to 2050. With an optimistically low rate
of growth of AMR, the “simulated losses of world output exceed $1 trillion annually after
2030 and reach $2 trillion annually by 2050” (Olusoji et al., 2017, p. 18). On the other
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hand, if the rate of growth of AMR was high, “the absolute levels are three times as high,
reaching $3.4 trillion annually by 2030 and rising further annually to $6.1 trillion
annually by 2050” (Olusoji et al., 2017, p. 19). These costs are extremely high and
indicate that putting resources into reducing AMR now is the best investment a country
can make in helping to decrease costs.
Morbidity/Mortality
Not only are the financial costs enormous, but so is the impact of antimicrobial
resistance on morbidity and mortality from these infections. It is estimated that by 2050
there will be 317,000 deaths yearly in the U.S. related to AMR (King, 2014). Deaths are
even higher in other continents such as Africa and Asia where they are estimated to be
over 4 million in each continent. Currently, there are an estimated 23,000 individual
deaths per year related to antimicrobial resistance (CDC, 2013).
Children receive a lot of primary care health services and because of this they
receive a disproportionately high number of antibiotics compared to the middle-aged
population (Ready et al., 2004). Antibiotics alone are the most common cause of adverse
drug events implicated in emergency department visits among children aged 5 years or
younger, with 32% of adverse drug events in children and adolescents aged 6 to 19 being
caused by antibiotics (Shehab et al., 2016).
From 2011 to 2015, there were an estimated 69,464 emergency department (ED)
annual visits for adverse drug events caused by antibiotics by children younger than 19
years old and younger (Lovegrove, et al., 2018). The majority of these visits (86%)
involved an allergic reaction, mainly mild rashes or itchy skin, but also included life
threatening reactions such as anaphylaxis or angioedema. More than 95% of these visits
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to the ED involved the patients being on a single oral antibiotic. The researchers found
that the risk for adverse drug event was higher for younger children. The researchers in
these studies suggest that a way to prevent these reactions is to avoid prescribing
antibiotics unnecessarily.
Inappropriate Antimicrobial Use
In an adult based study conducted by Fleming-Dutra et al. (2016) it was shown
that in the U.S. between 2010 and 2011, there was an annual antibiotic prescription rate
of 506 per 1000 patient visits, but only an estimated 353 of these antibiotics were likely
appropriate. Sinusitis was the diagnosis associated with the most antibiotic
prescriptions, followed by otitis media and pharyngitis (Fleming-Dutra et al., 2016).
Only 50% of the antibiotic prescriptions for these conditions were appropriately
prescribed. Fleming-Dutra et al. (2018) again looked at antibiotic prescribing rates in the
pediatric population specifically, finding that in 2013, 66.8 million antibiotics were
prescribed to the U.S. children ≤ 19 years of age; amoxicillin and azithromycin being the
two most commonly prescribed antibiotics. Pediatricians prescribed the most antibiotics,
followed then by family practitioners who were more likely to prescribe azithromycin in
all age groups (Fleming-Dutra et al., 2018). These findings correlate with a study
published by Hicks et al. (2015) who reported that penicillins were the most commonly
prescribed antibiotic class, and azithromycin was the most commonly prescribed
antibiotic. Fleming-Dutra et al. (2018) suggested that public health interventions should
focus on improving antibiotic selection in the pediatric population.
Children with upper respiratory tract infections are often prescribed broadspectrum antibiotics, which leads to the emergence of resistant bacteria (Alzahrani,
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Maneno, Daftary, Wingate, & Ettienne, 2018). Alzahrani et al. (2018) found that 39% of
the children were prescribed a broad-spectrum antibiotic. These prescriptions accounted
for an estimated 6.8 million visits annually. The two diagnoses attributing to the greater
odds of a broad-spectrum antibiotic prescription were acute sinusitis and acute otitis
media.
The problem of over-prescribing antibiotics is multi-factorial; one of the most
important contributors is the providers’ concerns to meet a perceived patient expectation.
Fletcher-Lartey et al. (2016) reported that 57% of general providers would often
prescribe an antibiotic for an upper respiratory tract infection (known to be of viral origin
by the provider) only to meet patient expectations. Other possible contributors to
overprescribing may be the fear about whether the infection may be bacterial and missed
(Teepe et al., 2016), the ease of antibiotic prescribing and the time-consuming process of
discussion regarding a viral process and not needing an antibiotic prescription.
Possible Solutions
Provider Based Education
One approach to solving the issue of the over prescribing of antibiotics is
provider-based education. A study conducted by Al-Twafiq and Alawami (2017)
examined a multifaceted approach to decrease inappropriate antibiotic use in upper
respiratory tract infections in outpatient pediatric clinics. Interventions included
educational grand rounds, academic training in small rounds and with individuals, audits,
feedback, and peer comparisons (Al-Tawfiq & Alawami, 2017). The authors were able
to show an improvement in antibiotic use with a decrease in inappropriate antibiotic
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prescriptions from 12 % to 4% using the above educational approaches (Al-Tawfiq &
Alawami, 2017, para. 3).
Link et al. (2016) conducted a quality improvement project in a central North
Carolina urgent care, to determine whether education would improve providers’
inappropriate antibiotic prescriptions for healthy adults with uncomplicated acute
bronchitis. Twenty providers attended at least one of the four training sessions offered,
which included face-to-face interactive training that focused on factors associated with
inappropriate prescribing, the current clinical guidelines, and patient communication
(Link et al., 2016). A retrospective chart review of the 217 pre-testing encounters and
335 post-training encounters by 19 providers demonstrated a 62% reduction in
inappropriate antibiotic prescribing (Link et al., 2016).
Electronic Clinical Decision Support Tools (ECDST)
Decision support tools can have a significant impact on provider prescribing as seen
in a study by McCullough et al. (2014) who evaluated the antibiotic prescribing rates for
acute bronchitis and upper respiratory infections in the National Ambulatory Medical
Care Survey data from 2006 to 2010. The use of decision support rose from 16% in 2006
to 50% in 2010, with the use of a decision support tool being associated with a 19%
lower likelihood of providing an antibiotic prescription.
Panesar et al. (2016) assessed the attitudes and behaviors of prescribers after
replacing a paper based antimicrobial prescribing guide with a smartphone app, a form of
ECDST, using two structured cross-sectional questionnaires. The researchers found that
the smartphone app was used more frequently, was found useful, and allowed users to
challenge their peers’ inappropriate antimicrobial prescribing (Panesar, et al., 2016).
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ECDST can be an effective format to deliver guidance on antimicrobial prescribing and
support antimicrobial stewardship efforts.
Charani et al. (2017) evaluated a similar ECDST for antibiotic prescribing by
adding a mobile health app to an established antimicrobial stewardship program (ASP).
The researchers used a segmented regression analysis to assess the impact of the apps
prescribing indicators. They found that there was an increase in compliance with policy
(such as empirical therapy and expert advice) in both medical and surgical units when the
app was used (Charani, et al., 2017, p. 1825).
Similarly, Fralick et al. (2017) evaluated whether a smartphone app with local
bacterial resistance patterns (antibiogram) and treatment guidelines could improve
medical trainees’ knowledge for prescribing antimicrobials. They found a significant
change in knowledge for participants who used the app compared to the control group.
Most students found the app easy to navigate, and useful, and about 25% continued to use
it daily. Findings from these studies reinforce the idea that ECDST can be a useful
innovative way to deliver antimicrobial education to providers.
Summary
Antibiotic use around the world has increased, and so has the increase in
antimicrobial resistance. The pediatric population is a key group that should be focused
on to help reduce this issue. Antibiotics are continuously prescribed inappropriately,
often without indication. The medications can be harmful in the short-term but can also
cause antibiotic resistance in the long-term. Resistant bacteria are continuously
becoming more prevalent in our communities, with children being hosts to the bacteria.
The focus should be on treating infections appropriately with evidence based clinical
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guidelines. ECDST has been shown as a useful way to deliver education and increase
awareness of treatment guidelines.
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Chapter III

Methods

Antibiotic resistance is a threat to every individual person, with the problem
increasing every day. The problem increases when providers prescribe antimicrobials
when there is no clinical indication for their use. Antimicrobial resistant infections are
life threatening with a significant amount of deaths occurring worldwide every year
because of them. With the ECDST, it was the researcher’s goal to provide an easily
usable tool to help providers in choosing the appropriate treatment for common infections
seen in the pediatric population to decrease the use of inappropriate antibiotic
prescriptions.
Project Design
This scholarly project was a descriptive vignette-based study to evaluate the effect
of ECDST on antibiotic prescribing practices for providers seeing pediatric patients
presenting with common infectious etiologies in outpatient rural health clinics.
Participants completed two different case scenarios using the ECDST as well as
completing usability assessments and assessments of cognitive effort when choosing
antibiotics for patients in the clinical scenarios.
Participants completed a pre-survey asking about their prior exposure and
familiarity with ECDST. Demographic information was collected including: the
17

participants’ gender, age range, provider type, and percentage of pediatric patients seen
weekly. During each case scenario participants used a computerized PowerPoint
equipped with easy to navigate interactive information from the American Association of
Pediatrics (AAP) or the Infectious Disease Society of America (IDSA) guidelines for
treating infectious diagnoses commonly encountered in the outpatient settings.
After completion of the case studies, participants completed two standardized
surveys: one to assess the usability of the application (the System Usability Scale), and
the other to assess subjective mental workload using the NASA Task Load Index (Hart &
Staveland, 1988). A comment section was also be provided for participants to provide
feedback on the ECDST, and a question about the likelihood of using this ECDST in their
practice. The SUS and NASA Task Load Index creators did not require permission for
their forms to be duplicated.
Target Population
Attempts were made to enroll a minimum of 10 practitioners who worked at
Community Health Center of Southeast Kansas (CHC SEK). The CHC SEK includes
providers with varied training backgrounds including Family Physicians, Pediatricians,
Physician Assistants and Family Nurse Practitioners. Inclusion criteria included all
providers working with pediatric patients, employed at CHC SEK at any of their practice
locations. Exclusion criteria included any providers who do not work with pediatric
patients and providers who are not Family Physicians, Pediatricians, Physician
Assistants, and Family Nurse Practitioners who work at one of the CHC SEK clinics.
The researcher recruited participants based on information provided by clinical
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administration at CHC SEK. The researcher approached the clinic administration for
permission to contact eligible providers.
The researcher approached the participants at the CHC of SEK during regular
business hours. Additional attempts were be made by email with providers and requested
their voluntary participation. The researcher met with each participant individually when
they were available throughout the day and strove to accommodate each participant’s
schedule. The researcher did not keep any identifying information including emails or
phone numbers, which were deleted after each contact.
Protection of Human Subjects
Prior to enrolling participants in this study, an Application for Approval of
Investigations was submitted to Pittsburg State University’s (PSU) Institutional Review
Board (IRB). An Exemption for Research Involving Human Subjects Criteria Form was
obtained allowing for the project to be exempt from review by the entire Committee for
the Protection of Human Research Subjects (CPHRS). The research project was
submitted under exemption status because the research was on individual perceptions
using a survey without the information being obtained and recorded in such a manner that
human subjects could be identified, directly or through identifiers linked to the subjects,
or any disclosure of the human subjects' responses outside the research could reasonably
place the subjects at risk of criminal or civil liability or be damaging to the subjects'
financial standing, employability, or reputation. The benefits of the present study were
that the providers will be educated on an ECDST to help choose a treatment for common
infections seen in the pediatric population. After IRB approval from PSU was obtained, a
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Statement of Mutual Agreement with CHC SEK was also obtained before enrolling
participants.
ECDST Development
The ECDST for this study was an interactive PowerPoint created using Microsoft
PowerPoint® by the author using the AAP and IDSA evidence based clinical guidelines
for diagnosis and management of common pediatric infections. Guidelines for otitis
media, sinusitis, pharyngitis, uncomplicated community acquired pneumonia (CAP),
urinary tract infections (UTI) and skin and soft tissue infections were included within the
slides. Questions regarding each disease process were incorporated into each slide, with
the corresponding answer linking the participant to the next slide based on the answer
they chose. Based on the answers to each question, participants were guided to the
different treatment options for each diagnosis. A “home” button and “back” button were
also incorporated to allow for users to navigate to the beginning slide or the previous
slide.
Instruments
The study used two different case scenarios involving fictional pediatric patients
with common infections seen in outpatient clinics. Each case scenario asked questions
that the participants answered using the ECDST. Each participant answered each
question on a printed case study. The researcher graded each case against the answer key
for each scenario.
At the completion of the cases, participants were asked to perform a survey
regarding usability and mental workload of the ECDST. The usability of the ECDST was
assessed using the System Usability Scale (SUS) (Brooke, 1986). The SUS is a ten-
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question Likert scale that quantifies the subjective assessment of usability. Each item on
the SUS has a value from one to five based on their level of agreement with the question.
When finding the SUS score, each odd number question is subtracted by one and on the
even number questions the number five is subtracted from each questions value. The
new values were added together for the total and then multiplied by 2.5. Each score is
out of a total of 100 points. If the total score is 80.3 or higher, it is considered a good
score with a total score of less than 51.0 considered a poor score.
The mental workload of the ECDST was evaluated using the NASA Task Load
Index (NASA TLX) (Hart & Staveland, 1988). The NASA TLX is a tool used for
measuring and conducting subjective mental workload. The tool determines the mental
work load for each participant based on six dimensions. The six dimensions include:
mental demand, physical demand, temporal demand, effort, performance, and frustration
level. Each participant was asked to rate their score on an interval rating from low (1) to
high (21).
Procedure
An Application for Approval of Investigations was submitted in October 2018 to
PSU’s IRB along with an Exemption for Research Involving Human Subjects Criteria
Form allowing for the project to be exempt from review by the CPHRS. After IRB
approval was obtained, a Statement of Mutual Agreement with CHC SEK was al
obtained. Recruitment of participants and collection of data occurred in December 2018.
The evaluation of the results from the data collected occurred in February, with the edits
and discussion occurring in March and April of 2019. The project was completed in May
of 2019.
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The resources needed to complete this project included computer access, no
personnel except the researcher, and no financing. Marketing analysis, strategic analysis
and products/services were not needed to complete the project. Subjects were identified
from a list provided by administration at CHC SEK. Providers including Family
Physicians, Pediatricians, Physician Assistants and Family Nurse Practitioners who see
pediatric patients were approached by the researcher either in person, by email, or phone.
Once participants were identified, each participant was assigned an individual
research identifier that did not contain any personal identifying information. Informed
consent for each participant was obtained. Prior to beginning each simulation, each
participant completed a pre-survey. The participants then completed two tests with
simulated case scenarios each using the ECDST. A computer with the ECDST was
provided for the participant. After completing the two clinical scenarios, each participant
was asked to complete the SUS, NASA TLX assessments, and a post-test survey. All
data, results, and information collected from the study were uploaded to a password
protected computer maintained securely for two years by the lead researcher.
Treatment of Data and Evaluation Plan
The potential role of the ECDST for optimizing antibiotic prescribing practices in
rural clinical practice along with the usability and acceptability was evaluated using
feedback from each participant after completing the clinical scenarios, post survey, SUS,
and NASA-TLX. The primary hypothesis that providers would find that the ECDST
requires a low mental demand and has a high usability value along with the aim that
providers would more often choose the correct diagnosis and related treatment when
using the ECDST was evaluated using the data collected from each individual participant.
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After the collection of data, the process of data analysis began. The two case
scenario scores were calculated based on the answers that the participants provided for
the each scenario. There were three questions for each scenario for a total of six
questions. The scores were calculated for each case study as a percentage out of a high
score of one hundred percent. It was elected to include median and interquartile range in
the data analysis because of the small sample size. The pre and post-survey answers were
analyzed with the total of each answer calculated and represented graphically. The SUS
scores were analyzed with each odd number question subtracted by one and with the even
number questions the number five is subtracted from each questions value. The new
values were added together for the total and then multiplied by 2.5. Each score is out of a
total of 100 points. The overall rating combined from each participant score from the six
categories and the total weighted score will be graphically represented.
There is currently no plan for sustainability.
Summary
Throughout this section, there was a discussion of the population to be studied,
procedure for data collection, development of the ECDST and its implications for data
analysis. By obtaining the SUS and NASA TLX scores, the mental demand and usability
of the ECDST were evaluated. The case study scores data were used to analyze whether
or not the ECDST will allow for providers to choose the right diagnosis and treatment
options for common pediatric infectious diseases in rural outpatient health clinics.
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Chapter IV

Evaluation Results

Introduction
The purpose of this project was to determine the potential role of an ECDST for
optimizing antibiotic prescribing practices in rural clinical practice. The specific aim was
to evaluate the usability and acceptability of an ECDST for antibiotic prescribing in
pediatric patients in outpatient rural health clinics. The exploratory aim was to assess the
impact of ECDST use on antibiotic prescribing practices among healthcare providers who
use the tool. The primary hypothesis was that providers would find that the ECDST
requires a low mental demand and has a high usability value. Based on the exploratory
aim, it was hypothesized that providers would more often choose the correct diagnosis
and related treatment when using the ECDST.
Description of Population
The data for this study was collected throughout the month of December 2018.
Ten providers participated in the data collection process. All providers were CHC SEK
employees. Of the ten participants 70% identified themselves as female (n=7) and 30%
identified themselves as male. Fifty percent of the participants were between the ages of
30-39, 40% were between the ages of 40-49 and 10% were between the ages of 50-59,
(Table 1).
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Although the study set out to include a range of providers including Family Nurse
Practitioners, Family Physicians, Physician Assistants and Pediatricians; the providers
who participated included Family Nurse Practitioners (n=7), Physician Assistants (n=2)
and one Pediatrician (n=1), (Table 1).
Table 1
Demographics
Items
Gender
Female
Male
Age
30-39
40-49
50-59
Provider Type
Family Nurse Practitioner
Pediatrician
Physician Assistant

Frequency (%)
7 (70)
3 (30)
5 (50)
4 (40)
1 (10)
7 (70)
1 (10)
2 (20)

The percent of pediatric patients seen by each provider weekly varied. The majority
(50%) of the participants see an average of 50% pediatric cases weekly, while four
providers see 25% pediatric patients weekly and one provider only sees pediatric patients
in their practice (Figure 1).
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Percentage of pediatric patients seen weekly
60%
50%
40%
30%
20%
10%
0%
25%

50%

75%

100%

Figure 1. Pre-Survey: Percentage of Pediatric Patients Seen Weekly
Statistical Analyses
To gather additional data on electronic clinical decision support tools in general
and assess the participants prior knowledge about these tools, the participants completed
a pre-survey (Appendix A) before conducting the case studies using the researcher’s
developed ECDST. The first question addressed the participants comfort level with using
electronic clinical decision support tools using a scale from one to five, five being very
comfortable and one being uncomfortable. The participants chose the number four 50%
of the time, five 40% (n=4) and three 10% (n=1) of the time (Figure 2).
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On a scale from 1-5, with 5 being very
comfortable and 1 being uncomfortable, what
would you rate your comfort with using
electronic clinical decision support tools?
60%
50%
40%
30%
20%
10%
0%
1

2

3

4

5

Figure 2. Pre-Survey: Question 1
Participants were asked how often they use their computer, phone, or tablet in
practice to help with clinical decision, to look up information, to look up dosing of
medication, etc. (other than use of calculator or to chart). All (n=10) of the participants
said that they used their electronic devices “multiple times a day” to help with clinical
decisions. To look for diagnosis and treatment options, 100% (n=10) of the participants
use UpToDate, 30% (n=3) use text books, 30% (n=3) wrote that they use Epocrates and
one participant uses YouTube as a source of information. (Appendix A) (Figure 3).
Where do you most often look for diagnosis
and treatment options?
120%
100%
80%
60%
40%
20%
0%
Textbooks

Other
books

Google UpToDate Medscape

Figure 3. Pre-Survey: Question 4
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Other

To assess the participant’s willingness to adopt an ECDST in their practice, the
researcher asked what the reasons were that the participants would use an electronic
clinical decision support system (Appendix A). The majority (90%) of participants chose
that they would use an electronic support tool because it’s easy to find information and it
uses clinical practice guidelines (Figure 3). Other reasons included presentation,
decreasing chance of medical error, improves quality of patient care, and one participant
wrote in “timely” as a reason they would use an electronic support tool in their job
(Figure 4).
What are the reasons you would use an electronic
clinical decision support tool in your job?
100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
Easy to find
Present
Decreases
Improves Uses clinical
information information chance of
quality of
practice
nicely
medical error patient care guidelines

Other

Figure 4. Pre-Survey: Question 5
To assess for possible obstacles in implementing an ECDST in rural outpatient
health care clinics, the researcher asked what the reasons are the participants would not
use an ECDST in their job (Appendix A). Over half (60%) of the participants chose lack
of time/time constraint as a reason they would not use an ECDST in their job. Other
reasons included competing clinical demands (20%), interference in work flow (10%),
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poor system design (20%), lack of computer/phone skills (10%) and do not want to use in
front of patients (10%) (Figure 5).

What are the reasons you would not use an electronic clinical
decision support tool in your job?
70%
60%
50%
40%
30%
20%
10%
0%

Figure 5. Pre-Survey: Question 6
Analysis of Hypotheses
The primary purpose of this study was to determine the potential role of an
ECDST for optimizing antibiotic prescribing practices in rural clinical practice. The
researcher asked each participant to complete two case studies while using the developed
ECDST. The first case study (Appendix B) asked three questions about the diagnosis and
treatment for a pediatric patient with acute otitis media. The median total score for case
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study number one was 83% with an Interquartile range (IQR) of 59% (Table 2). The
second case study (Appendix D) asked three questions about the diagnosis and
management for a pediatric patient with acute bacterial rhinosinusitis. The median total
score for this case study was 100% with an IQR of 34%. The hypothesis that the
participants would choose the correct diagnosis and treatment options the majority of the
time while using the ECDST was met.
Table 2
Case Study Results
Case Study 1
Case Study 2

Mean
73%
77%

SD
31%
35%

Median
83%
100%

Q1
41%
66%

Q2
100%
100%

IQR
59%
34%

The primary hypothesis was that providers would find that the ECDST requires a
low mental demand and has a high usability value. The usability of the study was
determined by analyzing the System Usability Scale (SUS) scores for each participant.
See Appendix D for the System Usability Scale used in the data collection process. The
median SUS score for all participants was 93.75 with an IQR of 12.5 meaning that the
ECDST has a high usability value based on the participants overall rating of the system.
Using the NASA-TLX rating scale the participants rated their experience using the
ECDST on mental demand, physical demand, temporal demand, performance, effort and
frustration (Appendix E). The scale is numbered from one to 21, with 1-4 being very low
and 18-21 being very high or requiring more demand. The median score for mental
demand was 2 (IQR 6.75). The median scores for physical demands, temporal demand,
performance, effort and frustration were all in the very low category as represented in
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Table 3. This indicates that participants found the ECDT tool to be very convenient and
easy to use making their task manageable with very little stress.
Table 3
NASA-TLX Results
Mental Demand
Physical Demand
Temporal Demand
Performance
Effort
Frustration

Mean
4.5
1.3
1.9
1.3
1.5
2.8

SD
4.28
0.67
1.45
0.48
0.97
3.16

Median
2
1
1
1
1
1

Q1
1
1
1
1
1
1

Q2
7.75
1
2
1.75
1.75
1.75

IQR
6.75
0
1
0.75
0.75
0.75

After each participant completed the case studies, they completed a post survey
(Appendix F). When asked “Did the electronic clinical decision support tool change the
way you diagnosed the patient?” 100% (n=10) of the participants did not find that the
tool changed the way they diagnosed the patient; however, when asked “did the
electronic clinical decision support tool change the way you treated the patient?” Sixty
percent of the participants said that yes it did change the way they treated the patient.
(Figure 6).

Did the electronic clinical decision support
tool change the way you treated the patient?
70%
60%
50%
40%
30%
20%
10%
0%
Yes

No

Figure 6. Post Survey Question 2
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The post survey also asked, “Would you consider using this ECDST in your future
practice?” This question helped to assess the acceptability of the ECDST. The vast
majority (90%) of the participants said that they would consider using this tool in their
future practice. One participant commented “Nice Job! Very easy and would use!”
Summary
The purpose of this project was to determine the potential role of an ECDST for
optimizing antibiotic prescribing practices in rural clinical practice. The specific aim was
to evaluate the usability and acceptability of an ECDST for antibiotic prescribing in
pediatric patients in outpatient rural health clinics. It was found that the ECDST
implemented in this study has a high usability value, requires a low mental demand and
was generally accepted by the providers who used it. The providers who participated
included Family Nurse Practitioners, Physician Assistants, and a Pediatrician, with the
majority of the providers seeing pediatric patients as 50% of their practice. The majority
of participants were female between the ages of 30-39 years old. The providers use
established ECDST tools in their practice such as UpToDate and Epocrates. It was found
that the participants use these tools multiple times a day because the information is easy
to find, and the ECDST’s use clinical practice guidelines. The major obstacle to using
electronic support tools was found to be lack of time/time constraint.
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Chapter V

Discussion

Relationship of Outcomes to Research
The overall purpose of this study was to determine the usability and acceptability
of an ECDST designed to optimize antibiotic selection for pediatric patients in outpatient
rural healthcare clinics. It was discovered through this project that the antibiotic
prescribing ECDST has a high usability based on the data received from the ten
participants. The usability score of the ECDST was high (93.75) based on the SUS scale
used to measure it. The ECDST was accepted by the participants, with 90% of the
providers saying they would consider using the tool in their practice. The simulated case
studies used to assess the impact of the ECDST on the diagnosis and treatment of acute
otitis media and acute bacterial rhinosinusitis showed that the ECDST helped the
providers choose the correct diagnosis and treatment option over 70% of the time. Over
half of the participants (60%) said that the ECDST changed the way the treated the
simulated patient. This information shows that with the ECDST, antibiotic prescribing
was optimized for the infectious diagnosis and the correct treatment was initiated based
on evidence-based practice guidelines.
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Observations
The primary hypothesis that providers would find that the ECDST was usable
correlates with earlier findings from Fralick et al. (2017) who found that their smartphone
app with local antibiograms and appropriate treatment option was useful and easy to
navigate and Panesar et al. (2016) who found that their ECDST was also useful. The
providers who used the ECDST in this project accepted this tool and said they would use
it in their clinical practice. These finding correlate with previous studies who found that
ECDST’s could be incorporated into clinical practice (Fralick et al., 2017; Panesar et al.
2016., Charani et al., 2017; McCullough et al., 2014). It was also observed during this
project that the providers chose the correct treatment option for the diagnosis over 70% of
the time. These findings correlate with McCullough et al. (2014) who observed that an
ECDST can have a significant impact on providers prescribing. During this project it
was also found that 60% of the providers changed the way they prescribed an antibiotic
because of the ECDST. McCullough et al. (2014) also saw a change in prescribing
patterns with their ECDST which was associated with a 19% lower likelihood of
providing an antibiotic prescription.
Throughout the data collection process it was observed that time constraint plays
an important role in using ECDSTs in the clinical setting. The data for this project was
collected during normal business hours while the participants were in the clinical setting.
It was observed by the researcher that the participants were often busy with competing
demands of their time and were often hurried to complete the tasks because of these time
constraints. This observation correlates with the data that 60% of the participants say that
lack of time/time constraints play a big role in not using ECDST’s in their practice. It
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was also observed by the researcher that some of the participants chose treatment options
on the case studies that were not an option on the ECDST. This observation shows that
even with the available resources, inappropriate antibiotic selection and other treatment
options can still be made.
Limitations
The biggest limitation for this project is the sample size. With the sample size of
only ten participants, potential error or bias may exist. There were a disproportionally
higher number of family nurse practitioners (70%) who completed this study, with 50%
of the participants seeing pediatric patients as only half of their patient population. There
were also significantly more female participants compared to males who completed the
study. The study also failed to include family physicians in the data collection process.
There was also a time constraint of only one month available to collect data during the
data collection process that may have hindered the available sample size.
Evaluation of Theoretical Framework
The theoretical framework used in this project was Lawrence Kohlberg’s theory
of moral development. The theory of moral development framework was used to support
and reinforce the provider’s mission to improve overall care and promote accurate
knowledge to improve outcomes by incorporating evidence into practice. With the use of
evidence-based practice guidelines that are available in the ECDST, providers were able
to choose the correct antibiotic treatment for the pediatric illness most of the time. The
ECDST promotes knowledge and helps the provider choose appropriate treatment for the
diagnosis, which improves the overall care they give their patient. More information
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regarding the use of the ECDST and the providers moral development needs to be
gathered in future research.
Evaluation of Logic Model
The logic model used for this project correlates well with the research findings.
The logic model began with inputs including literature review, evidence-based practice
guidelines and development of an ECDST. The literature review was appropriate but
could have included more information about ECDSTs and their impact on antibiotic
prescribing. Outputs included activities and participation from the providers. The
sample size for this project was ten providers. The participation was lacking and could
have been increased by allowing more time for data collection. The short-term goals in
the logic model were that providers would become aware of the issue of antibiotic
resistance, find the ECDST usable and motivate providers to use the ECDST to prescribe
antibiotics appropriatley. These short-term goals were not all met. The problem of
antibiotic resistance was not fully discussed with the participants, and motivation to
change the way the providers prescribed antibiotics was not assessed. Other outcomes
include behavior changes and eventual policy and practice changes in the clinical setting.
This project did not address these future outcomes.
Implications for Future Projects and Research
Future research could include using this ECDST in other rural healthcare settings
with a larger provider population. Using the same methods used in this project with a
larger sample size, the impact of the ECDST can be further evaluated. The ECDST also
has guidelines for antibiotic selection for skin and soft tissue infections, pharyngitis,
urinary tract infections, and uncomplicated community acquired pneumonia, which could
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also be used in future projects. A quality improvement project could also be developed to
see if using the ECDST in the clinical setting impacts the way providers diagnose and
prescribe for common pediatric infections in rural healthcare settings. The ECDST could
be incorporated into an existing outpatient Antimicrobial Stewardship Program (ASP) or
be a tool that is used in creating a new ASP in an outpatient rural health care clinic. The
CDC’s CARB goal is to reduce inappropriate antibiotic prescribing by 50% by 2020
(CDC, 2017a). Future projects using this ECDST could look at the impact the tool has on
changing the percentage of inappropraite prescribing for certain disease processes that are
included in the ECDST. The design of this project could be improved upon for future
projects. More educational offerings on appropriate prescribing and its impact on
antibiotic resistance needs to be completed with the providers to help them understand
the role the ECDST can have on this issue.
Implications for Practice
The ECDST is designed to be a usable and easy tool for providers to use to
diagnose and treat common pediatric infections in the outpatient setting. It was found
that it has a high usability value and was accepted by the providers that used it. It can
easily be integrated into the clinical practice setting to optimize antibiotic selection for
pediatric infections. ECDST’s were already widely used by all the participants in their
everyday practice. It is suggested that providers integrate the developed ECDST into
their current clinical practice to optimize antibiotic selection and reduce inappropriate
prescribing. Advanced Practice Registered Nurses (APRNs) should continue to grow
their knowledge about appropriate antibiotic prescribing and use current practice
guidelines when treating their patients. This ECDST uses these practice guidelines and
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makes it easy for providers to choose appropriate treatment. APRNs should incorporate
these tools into their clinical practice to easily make these treatment decisions. The
ECDST could also be incorporated into an educational institutes graduate programs as an
educational tool for student APRNs to learn about diagnosing and treating common
pediatric infections.
Conclusion
The overall purpose of this project was to determine the usability and
acceptability of an ECDST designed to optimize antibiotic selection for pediatric patients
in outpatient rural healthcare clinics. It was discovered the antibiotic prescribing ECDST
has a high usability value, requires low mental demand, and was generally accepted by
the providers who used it. The ECDST used in this project can easily be integrated into
outpatient clinical settings to optimize antibiotic prescribing practices. With the use of
clinical practice guidelines used in the ECDST providers can feel confident knowing that
they’re treating their patient’s safety and doing their part to combat antimicrobial
resistance.

.
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APPENDIX

Appendix A
Pre-Survey
1. On a scale from 1-5, with 5 being very comfortable and 1 being uncomfortable, what
would you rate your comfort with using electronic clinical decision support tools?
o 1
o 2
o 3
o 4
o 5
2. How often do you use your computer, phone or tablet in practice to help with clinical
decisions, to look up information, to look up dosing of medication, etc (other than use of
calculator or to chart)?
o Multiple times a day
o Daily
o About once a week
o Monthly
o A few times a year
o Never
3. Which of the following electronic clinical decision support have you used or heard of?
(check all that apply)
o Electronic order set
o Medication dose calculator
o Medical reference tools
o I don’t know
o Other
4. Where do you most often look for diagnosis and treatment options?
o Text books
o Other books
o Google
o UpToDate
o Medscape
o Other_____________________________
o None
5. What are the reasons you would use an electronic clinical decision support tool in your
job? (check all that apply)
o It’s easy to find information with the electronic decision support system
o It presents information nicely
o It decreases chances of medical error
o It improves quality of patient care
o It uses clinical practice guidelines
o Other______________________________
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6. What are the reasons you would not use an electronic clinical decision support tool in
your job? (check all that apply)
o Lack of time/time constraint
o Competing clinical demands
o Interferes in work flow
o Too complicated
o Poor system design
o Lack of computer/phone skills
o Do not want to use in front of my patients
o Prior bad experience
o Not interested in using
o Lack of authenticity and reliability of information
o Other________________________________

Demographics
Gender: ___Male ____Female
Age: ___20-29 years ___30-39 years ___40-49 years ___50-59 years ___60 years or
older
Provider Type:
____ Family Nurse Practitioner
____ Specialty Nurse Practitioner ____________________
____ Pediatrician
____ Family Physician
____ Other________________________
Percent of pediatric patients seen weekly: ___25% ____ 50% ____75% ____100%
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Appendix B
Case Study 1
SUBJECTIVE (given by the patient’s mother)
CC: ear pain and fever
HPI: Jane is a 22-month-old, previously healthy female presenting with 2 days of fever
and pulling on her right ear. She had rhinorrhea, nasal congestion and cough for 5 days
starting last week which have improved. Today, she developed fever up to 38.8°C
(101.8°F). Mother reports patient is more tired than usual, taking additional naps during
the afternoon. Parent denies any change in feeding or elimination patterns. No sick
contacts. Attends daycare. She has not been on any antibiotics during the past 30 days.
Allergies: Penicillin (mild rash)
Immunizations: Up to date
OBJECTIVE
VS: T 38.5C (101.3F), RR 18 breaths/min, HR 84 beats/min, BP 96/52 mmHg, SpO2
99% on Room air, Weight 10.5kg, Height 77cm
General: Well nourished, no acute distress
HEENT: Eyes: sclera white, conjunctiva pink. Ears: clean canals bilaterally. Right
tympanic membrane intensely erythematous and bulging with diminished light
reflex, bony landmarks not visualized. No purulent drainage observed. No pain to
palpation of mastoid bone.
Neck: Supple, no masses, 1cm palpable right cervical lymph node, mobile nontender
Lungs: Clear to auscultation in all lobes, no wheezing, rhonchi, rales
Questions:
1. What is Jane’s diagnosis? _____________________________________
2. How would you manage Jane? ____________________________________
3. How would you manage Jane if had severe penicillin allergy (anaphylaxis)?
_______________________________________________________________
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Appendix C
Case Study 2
SUBJECTIVE (given by the patient’s mother)
CC: cough, rhinorrhea and fever
HPI: John is a previously healthy 4-year-old male presenting with persistent daily
purulent nasal discharge with daytime and nighttime cough for 11 days that is not
improving, associated with intermittent fever to 38.2°C (100.8°F). John has also
complained facial pain and intermittent headaches. John’s mother reports that he does not
attend daycare or school and stays at home with her during the day. He has had no sick
contacts. His mother has treated John with over the counter cough medication and
acetaminophen. He has not received any type of prescription medication in the last 30
days.
Allergies: penicillin (rash)
Immunizations: Up to date
OBJECTIVE
VS: T 38°C (100.4°F), RR 18 breaths/min, HR 85 beats/min, BP 100/72 mmHg, SpO2
99% on Room air, Weight 18kg, Height 101cm
General: Well nourished, no acute distress
HEENT: Ears: external canals clear bilaterally. Left and right tympanic membranes
pearly grey with positive light reflex and visible bony landmarks. Nose: nasal turbinate’s
erythematous and swollen with visible purulent nasal drainage. Mouth/Throat: moist
mucous membranes. Oropharynx clear without exudates. Uvula with mild erythema,
post-nasal drainage visualized on exam
Neck: Supple, no masses, no lymphadenopathy
Lungs: Clear to auscultation in all lobes, no wheezing, rhonchi, rales

Questions:
1. What is John’s diagnosis? _____________________________________
2. How would you manage John? ____________________________________
3. How would you manage John if he did not have any allergies?
_______________________________________________________________
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Appendix C
System Usability Scale

Instructions
Based on your experience today with the electronic clinical decision support tool
(ECDST), check the box that reflects your immediate response to each statement. Make
sure to respond to each question
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Appendix E
NASA TLX Survey
Instructions: circle the number on each scale that best indicates your experience with the
electronic clinical decision support tool (ECDST)

Mental Demand
How mentally demanding was the case with use of the app?
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

Very Low

20

21

Very High

Physical Demand
How physically demanding was the case with use of the app?
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

Very Low

20

21

Very High

Temporal Demand
How hurried or rushed was the pace of the case with use of the app?
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

Very Low

20

21

Very High

Performance
How successful were you in accomplishing what you were asked to do?
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

Perfect

21

Failure

Effort
How hard did you have to work to accomplish your level of performance?
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

Very Low

20

21

Very High

Frustration
How insecure, discouraged, irritated, stressed, and annoyed were you?
1

2

3

4

5

6

7

8

9

10

11

12

Very Low

13

14

15

16

17

18

19

20

21

Very High
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Appendix F
Post Survey
7. Did the electronic clinical decision support tool change the way you diagnosed the
patient?
o Yes
o No
o Other________________________________

8. Did the electronic clinical decision support tool change the way you treated the
patient?
o Yes
o No
o Other_________________________________

9. Would you consider using this ECDST in your future practice?
o Yes
o No
o Other_________________________________
10. Additional
comments________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
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